Enhanced therapeutic effects for human pancreatic cancer by application K-ras and IGF-IR antisense oligodeoxynucleotides

doi:10.3748/wjg.14.5176

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 33

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2901)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-7) series, Tables (1-1) series.

Item

Count

PDF

244

HTML

2327

Figures (1-7)

172

Tables (1-1)

158

Sum=2901

Sep 7, 2008 (publication date) through Sep 22, 2024

Times Cited of This Article

Times Cited (8)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Research

World J Gastroenterol. Sep 7, 2008; 14(33): 5176-5185
Published online Sep 7, 2008. doi: 10.3748/wjg.14.5176

Full Size Figure Download Figure

Figure 4 Apoptosis of Patu8988 cells detected by flow cytometry with Annexin V-FITC dual staining. A: Control group; B: IGF-IR ASODN group; C: K-ras ASODN group; D: K-ras ASODN + IGF-IR ASODN group; E: Apoptosis rate of Patu8988 cells for different groups. ^bP < 0.01, vs control group. Each value represents the mean ± SD from triplicate determinations.

Citation: Shen YM, Yang XC, Yang C, Shen JK. Enhanced therapeutic effects for human pancreatic cancer by application K-ras and IGF-IR antisense oligodeoxynucleotides. World J Gastroenterol 2008; 14(33): 5176-5185
URL: https://www.wjgnet.com/1007-9327/full/v14/i33/5176.htm
DOI: https://dx.doi.org/10.3748/wjg.14.5176